Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced it will present the final clinical results from...

– Vidofludimus Calcium Demonstrated Statistically Significant 24-Week Confirmed Disability Improvement in Phase 2 CALLIPER Trial in Progressive Multiple Sclerosis, With Over Two-Fold Probability...

Enhancements to the Pure Storage Platform ensure data is accessible wherever it's needed with workload coverage expansion into the cloud NEW YORK, Sept. 25, 2025 /PRNewswire/ -- Pure//Accelerate...

Expanded cyber risk capabilities improve organizations' ability to anticipate, address, and recover from today's most sophisticated cyber threats NEW YORK, Sept. 25, 2025 /PRNewswire/ --...

A premier opportunity for U.S. retailers, manufacturers, and designers to access India's thriving gem and jewelry sector with stipends, factory tours, and tailored support through USA Coordinator,...